These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2876508

  • 1. Pharmacokinetics of SMS 201-995 in healthy subjects.
    Kutz K, Nüesch E, Rosenthaler J.
    Scand J Gastroenterol Suppl; 1986; 119():65-72. PubMed ID: 2876508
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of subcutaneous injection of a long-acting analogue of somatostatin (SMS 201-995) on plasma thyroid-stimulating hormone in normal human subjects.
    Itoh S, Tanaka K, Kumagae M, Takeda F, Morio K, Kogure M, Hasegawa M, Horiuchi T, Watabe T, Miyabe S.
    Life Sci; 1988; 42(26):2691-9. PubMed ID: 2898717
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of the long-acting somatostatin analogue octreotide (SMS 201-995) in acromegaly.
    Nicholls J, Wynick D, Domin J, Sandler LM, Bloom SR.
    Clin Endocrinol (Oxf); 1990 May; 32(5):545-50. PubMed ID: 2364560
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human pharmacological effects of SMS 201-995 on gastric secretion.
    Gyr KE, Whitehouse I, Beglinger C, Köhler E, Dettwiler S, Fried M.
    Scand J Gastroenterol Suppl; 1986 May; 119():96-102. PubMed ID: 2876511
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure.
    Jenkins SA, Nott DM, Baxter JN.
    HPB Surg; 1998 May; 11(1):13-21. PubMed ID: 9830576
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans.
    Creutzfeldt W, Lembcke B, Fölsch UR, Schleser S, Koop I.
    Am J Med; 1987 May 29; 82(5B):49-54. PubMed ID: 2884879
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.
    Lamberts SW, Uitterlinden P, Verschoor L, van Dongen KJ, del Pozo E.
    N Engl J Med; 1985 Dec 19; 313(25):1576-80. PubMed ID: 2866445
    [Abstract] [Full Text] [Related]

  • 17. Interaction between growth hormone releasing factor (GRF) and somatostatin analogue (SMS 201-995) in normal subjects.
    Losa M, Müller OA, Sobieszczyk S, von Werder K.
    Clin Endocrinol (Oxf); 1985 Dec 19; 23(6):715-20. PubMed ID: 2869845
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.